Inclusion Criteria:

          1. ≥ 18 years of age

          2. Must provide written informed consent

          3. Presence of low or intermediate risk prostate cancer or at risk of having intermediate
             risk cancer

             a. Intermediate risk prostate cancer: i. Grade group 2 = 3 + 4, or ii. Grade group 3 =
             4 + 3 b. At Risk of intermediate risk prostate cancer: i. 4K score ≥ 20%, or ii.
             Select MDx ≥ 20%, or iii. PSA Density ≥ 0.15 iv. Grade group 1= 3+3 (iv. Note: Where
             multiple cancer lesions are present on biopsy, it is allowable to have Gleason 8 or 9
             cancer lesions if they are in addition to the intermediate risk cancer as described
             above.)

          4. Scheduled for MRI or has recently completed SOC MRI (within 6 months) for further
             biopsy, or surgical removal, or focal therapy.

          5. Willing and able to lie still for approximately 50 minutes in an enclosed space for
             the CT.

        Exclusion Criteria:

          1. Participation in another investigational trial involving research exposure to ionizing
             radiation concurrently or within 30 days.

          2. Does not meet safety criteria for MRI scan (e.g. metal implant that is not allowed).

          3. Significant acute or chronic medical, neurologic, or psychiatric illness in the
             subject that, in the judgment of the Principal Investigator, could compromise subject
             safety, limit the subject's ability to complete the study, and/or compromise the
             objectives of the study.